A double-blind, multicenter, international randomised study to assess the effects of 4 month-oral administration of 2g per day of strontium ranelate versus placebo on the bone quality and remodelling, as assessed on an alveolar bone biopsy extracted before dental implantation, in osteoporotic patients or in patients at risk of osteoporotic fracture [Studio multicentrico, internazionale, randomizzato in doppio cieco per valutare gli effetti di 4 mesi di somministrazione orale di 2 g al giorno di ranelato di stronzio verso placebo sulla qualita' dell'osso e sul rimodellamento dell'osso alveolare, valutato tramite biopsia estratta prima di un impianto dentario, in pazienti con osteoporosi o a rischio di frattura osteoporotica]

Trial Profile

A double-blind, multicenter, international randomised study to assess the effects of 4 month-oral administration of 2g per day of strontium ranelate versus placebo on the bone quality and remodelling, as assessed on an alveolar bone biopsy extracted before dental implantation, in osteoporotic patients or in patients at risk of osteoporotic fracture [Studio multicentrico, internazionale, randomizzato in doppio cieco per valutare gli effetti di 4 mesi di somministrazione orale di 2 g al giorno di ranelato di stronzio verso placebo sulla qualita' dell'osso e sul rimodellamento dell'osso alveolare, valutato tramite biopsia estratta prima di un impianto dentario, in pazienti con osteoporosi o a rischio di frattura osteoporotica]

Discontinued
Phase of Trial: Phase II

Latest Information Update: 13 Jul 2013

At a glance

  • Drugs Strontium ranelate (Primary)
  • Indications Fracture
  • Focus Therapeutic Use
  • Sponsors Servier
  • Most Recent Events

    • 24 May 2013 Status changed from recruiting to discontinued as reported by European Clinical Trials Database.
    • 03 Apr 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top